ACSM3
protein-codingacyl-CoA synthetase medium chain family member 3, the group of Acyl-CoA synthetase family
Gene summary
Enables medium-chain fatty acid-CoA ligase activity. Predicted to be involved in acyl-CoA metabolic process and fatty acid biosynthetic process. Located in mitochondrion. Implicated in IgA glomerulonephritis. Biomarker of ulcerative colitis. [provided by Alliance of Genome Resources, Jul 2025]
- SAH
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~187.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ACSM3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005622.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 4 | 6 | |||
| missense | 88 | 5 | 93 | |||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 0 | 0 | 97 | 9 | 0 | 106 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005613.2 | 13 | MANE Select | |
| Ensembl | ENSP00000289416.5 | 13 | MANE Select | |
| RefSeq | NP_973729.1 | 8 | Standard | |
| Ensembl | ENSP00000394565.2 | 8 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Butanoate metabolism - Homo sapiens (human)
- Valproic Acid Pathway, Pharmacokinetics
- Metabolism of lipids
- Beta oxidation of butanoyl-CoA to acetyl-CoA
- mitochondrial fatty acid beta-oxidation of saturated fatty acids
Biological Process
- fatty acid biosynthetic process
- acyl-CoA metabolic process
- regulation of blood pressure
- cholesterol homeostasis
Molecular Function
- molecular_function
- acyl-CoA ligase activity
- fatty-acyl-CoA synthase activity
- ATP binding
- fatty acid ligase activity
Cellular Component
- cellular_component
- mitochondrial matrix
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000289416
- Coding exons
- 13
- Length
- 187339
- Individuals with no LoFs
- 123187
- Homozygous LoFs
- 22
- Heterozygous LoFs
- 2539
- Defined
- 125748
- p
- 0.0102
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.456 | 290 | 313 | 0.927 | 0.0000158 | 3828 |
| Missense (PolyPhen) | 115 | 125.21 | 0.91847 | 1544 | ||
| Synonymous | 1.14 | 95 | 110 | 0.862 | 0.00000567 | 1115 |
| Loss of Function | 1.30 | 26 | 34.2 | 0.761 | 0.00000196 | 381 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.040 | 0.040 | notable |
| Latino/Admixed American | 0.0088 | 0.0087 | notable |
| Ashkenazi Jewish | 0.0078 | 0.0078 | notable |
| East Asian | 0.00077 | 0.00076 | rare |
| Finnish | 0.0018 | 0.0018 | notable |
| European (Non-Finnish) | 0.010 | 0.010 | notable |
| South Asian | 0.0088 | 0.0088 | notable |
| Other | 0.0090 | 0.0090 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4- unsaturated acids (in vitro) (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.455
Intolerance Scores
- LoFtool
- 0.959
- RVIS EVS
- 1.29
- RVIS percentile EVS
- 93.85
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.276
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |